(Q34628946)
Statements
1 reference
Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: nonclinical Pharm/Tox analysis and the role of comparative toxicology (English)
1 reference
Kuei-Meng Wu
1 reference
James G Farrelly
1 reference
21 April 2007
1 reference
1 reference
236
1 reference
1-2
1 reference
1-6
1 reference
Identifiers
1 reference
1 reference